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Summary 
The cyanobacteria Microcystis proliferate in freshwater ecosystems and produce bioactive 
compounds including the harmful toxins, microcystins (MC). These secondary metabolites play 
an important role in shaping community composition through biotic interactions although their 
role and mode of regulation are poorly understood. As natural cyanobacterial populations include 
producing and non-producing strains, we tested if the production of a range of peptides by co-
existing cells could be regulated through intraspecific interactions. With an innovative co-
culturing chamber together with advanced mass spectrometry (MS) techniques, we monitored the 
growth and compared the metabolic profiles of a MC-producing as well as two non-MC-
producing Microcystis strains under mono- and co-culture conditions. In monocultures, these 
strains grew comparably; however, the non-MC-producing mutant produced higher 
concentrations of cyanopeptolins, aerucyclamides and aeruginosins than the wild-type. 
Physiological responses to co-culturing were reflected in a quantitative change in the production 
of the major peptides. Using a MS/MS-based molecular networking approach we identified new 
analogues of known classes of peptides as well as new compounds. This work provides new 
insights into the factors that regulate the production of MC and other secondary metabolites in 
cyanobacteria, and suggests interchangeable or complementary functions allowing bloom-
forming cyanobacteria to efficiently colonize and dominate in fluctuating aquatic environments. 
 
Introduction 
Freshwater cyanobacteria of the genus Microcystis proliferate in many aquatic ecosystems, and 
due to expected climate and anthropogenic changes, their blooms are predicted to increase in 
frequency and intensity (Paerl and Paul, 2012). Microcystis blooms strongly impact the 
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functioning of aquatic ecosystems and pose a risk to animal and human healths (Codd et al., 
2005; Zanchett and Oliveira-Filho, 2013) because of their ability to produce harmful toxins. 
Among these, the microcystins (MC), protein phosphatase 1 and 2A inhibitors (MacKintosh et 
al., 1990), are the most studied and widespread. 
Besides the microcystins, Microcystis spp. produces a variety of other bioactive 
compounds valuable for the biotechnological and biomedical industries (Sivonen and Börner, 
2008). They are classified into six major families depending on their structural characteristics: 
aeruginosins, anabaenopeptins, cyanobactins, cyanopeptolins, microginins and microviridins 
(Welker and von Döhren, 2006). In the last decade, efforts have been dedicated to understand the 
biosynthesis of these cyanopeptides. They originate from pathways involving ribosomally 
synthesized and post-translationally modified peptides (RiPP), non-ribosomal peptide 
synthetases (NRPS) or mixed polyketide synthases (PKS-NRPS) (Kehr et al., 2011). A number 
of bioactivities have been reported for these peptides, including cytotoxic, antiviral, antimalarial 
or allelopathic (Portmann et al., 2008a, b; Sivonen et al., 2010), and the biological mechanisms 
of action are generally through inhibition of vital eukaryotic enzymes (Ishitsuka et al., 1990; 
Ishida et al., 2000; Itou et al., 1999; Bister et al., 2004; Ersmark et al., 2008; Sivonen et al., 
2010). Despite significant advances in our understanding of the metabolic pathways involved in 
their production, and of their biological activities, the natural functions and the ecological roles 
played by these metabolites are still not well understood.  
The biosynthesis of cyanobacterial secondary metabolites consumes a great deal of 
metabolic energy at significant cost to the cell (Herms and Mattson, 1992). Hence, clues to the 
function of these compounds may be obtained by exploring the growth conditions under which 
they are produced. To date, most effort at understanding the function of cyanopeptides has 
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focused on MC. However, even for the best-studied cyanotoxins, several functions are disputed 
for both the intra- and extracellular forms (for a review see Kaplan et al., 2012). There have been 
few studies on the other cyanopeptides, and these have mainly focused on their production in 
several cyanobacterial strains under different growth conditions. The study performed by 
Rohrlack and Utkilen (2007) on the effects of nutrient and light availability on production of 
anabaenopeptins and microviridins by Planktothrix showed similar patterns of regulation to that 
of the microcystins, e.g. higher production of the compounds under optimal growth rate 
conditions (Orr and Jones, 1998). Also, comparison of the production of bioactive compounds by 
Anabaena sp. 90 and its genetically engineered anabaenopeptilide-deficient mutant under various 
light and phosphate levels revealed that the loss of this oligopeptide resulted in a production 
increase of the remaining metabolites (Repka et al., 2004). Compensatory mechanisms between 
and within peptide classes were also observed for Microcystis (Tonk et al., 2005), Planktothrix 
(Tonk et al., 2009) and Radiocystis (Pereira et al., 2012) in response to various growth 
conditions. Hence a better understanding of the possible functions of these metabolites requires a 
holistic approach rather than focusing on a single compound in particular as natural 
cyanobacterial populations consist of a mixture of producing and non-producing strains for each 
class of bioactive peptides (Fastner et al., 2001; Welker et al., 2004). Thus, it can be speculated 
that the production of a range of peptide variants by co-existing cells may be regulated through 
intraspecific interactions.  
To investigate this hypothesis, we studied Microcystis aeruginosa strains with the 
potential to produce several secondary metabolites under different culture conditions. We first 
compared the growth and the production of bioactive peptides in monoculture of a wild type 
strain PCC 7806 (WT), its MC-deficient mutant (MT) and a naturally non-MC-producing strain 
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PCC 9432 (NT). Secondly, we explored whether co-culturing the MC- with one of the non-MC-
producing strains affected the growth or the production of cyanopeptides of each strain. For these 
purposes, we developed a co-culturing chamber device and evaluated variations in metabolite 
production using MS/MS molecular networking (Wartrous et al., 2012).   
 
Results 
Growth of Microcystis aeruginosa strains in mono-, co-culture and MC-LR addition 
experiments. The growth of the three strains (WT, MT and NT) displayed the same growth rates 
in monoculture (Table 1). In the WT/MT co-culture experiment, no significant difference was 
observed in growth of WT and MT, whereas in WT/NT co-culture experiment, the NT exhibited 
a higher growth rate (0.15 ± 0.005 day-1) than the WT (0.10 ± 0.015 day-1). In addition, purified 
MC-LR added to the MT monoculture did not impact its growth response (Table 1). 
Description of secondary metabolic profiles of Microcystis aeruginosa strains in 
monocultures. For the three strains in monoculture, we could identify by LC-MS 12 peptides 
produced by the WT, the same ones without microcystins by the MT, and 12 others by the NT 
(Fig. 1). From these 24 metabolites (Table 2), 14 could be identified as previously described 
compounds: 2 anabaenopeptins (compounds 18-19, Fig. 1C), 6 cyanobactins (compounds 2, 10-
12, Fig. 1A and B, compounds 16-17, Fig. 1C), 4 cyanopeptolins (compounds 5-8, Fig. 1A and 
B) and 2 microcystins (compounds 3-4, Fig. 1A) and these compounds were added to the Global 
Natural Products Social Molecular Networking (GNPS) library (see Experimental Procedures). 
A total of seven other peptides could be identified as members of a known peptide class: one Cl2-
aeruginosin (compound 1, Fig. 1A and B, Fig. S1), six cyanopeptolins (compound 9, Fig. 1A and 
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B and compounds 20-24, Fig. 1C), while three peptides remain uncharacterized (compounds 13-
15, Fig. 1C, Fig. S2).  
The cyanopeptolins were the main peptide class produced by all 3 strains, and 10 variants 
were identified (compounds 5-9 and 20-24 in Fig. 1). Cyanopeptolins are relatively easily 
identified from fragment spectra deriving from the highly conserved amino-hydroxy piperidone 
(Ahp) unit (Welker et al., 2006). Four were already described cyanopeptolin metabolites (Cya A, 
B, C and Cya 963A with a quasi-molecular ion at m/z 946 [M-H2O]
+), whereas the other six are 
new species with m/z 896, 915, 949, 963, 965 and 979 Da (Fig. S3 and S4). Fragment patterns 
obtained from several cyanopeptolin variants (Cya A, B, C, 895 and 963A) produced by the WT 
and MT strains showed a diagnostic series of fragments indicative of the partial structure Ahp–
Leu–MePhe (m/z 134, 181, 209, 258 and 370; Fig. S3). The cyanopeptolins produced by the NT 
presented another partial sequence, Ahp–Phe–MePhe, as characterized by the following series of 
fragments m/z 134, 215, 243, 292 and 404 (Fig. S4). 
Additionally, several cyanobactins were produced by the three strains, all corresponding 
to previously identified compounds. The WT and MT strains produced the cyclic ribosomal 
peptides aerucyclamide A, B, C and D (respectively, compounds 10, 11, 12 and 2 in Fig. 1A and 
B) and the NT produced two short linear cyanobactins: aeruginosamide B and C (compounds 16 
and 17 in Fig. 1C). Also, two anabaenopeptins produced by the NT were identified as the cyclic 
hexapeptides ferintoic acids A and B (compounds 18 and 19 in Fig. 1C). 
Changes in the production of the major cyanopeptides by Microcystis aeruginosa strains in 
mono- and co-culture. We studied changes in cyanopeptides production (1) by the engineered 
MT when compared to its WT in monoculture and (2) by the three strains in response to 
intraspecific strain interactions. WT and MT strains produced the same peptides besides MC, 
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while the NT produced completely different peptides than the other two strains. Hence for the 
WT in co-culture and the MT in mono- and co-culture, we normalized the concentrations against 
the WT in monoculture, while for the NT in co-culture we normalized against NT in 
monoculture. 
Figure 2A shows the relative concentrations of the major intracellular compounds for the 
WT and MT strains under mono- and co-culture conditions. MT, unable to produce any MC, 
produced significantly greater concentrations of Arg 684, Cya 963A, Aer A, B and C compared 
to WT in monoculture condition (WT in WT/WT versus MT in MT/MT). Also, a significant 
production increase of the compounds produced by WT and MT, with the exception of des-
MCLR and Aer D, was observed in the co-culture treatments (WT in WT/WT versus WT in 
WT/MT and MT in MT/MT versus MT in WT/MT). The up-regulated compounds observed 
under WT/MT co-culture condition were always higher in MT cells than in WT cells (WT in 
WT/MT versus MT in WT/MT). We further investigated the effects of adding purified MC-LR 
on the intracellular metabolic profile of MT in monoculture (Fig. S5). No significant change in 
the production of peptides between the MT and MT+MCLR in monoculture was observed (MT 
in MT/MT versus MT+MCLR in MT/MT). Moreover the peptides concentrations in MT+MCLR 
were always lower than in MT cells under co-culture conditions (MT in WT/MT versus 
MT+MCLR in MT/MT). Also, no significant difference was observed in the production of the 
compounds by the WT when co-cultured with the NT (WT in WT/WT versus WT in WT/NT). 
However, a significant production increase of five major compounds produced by NT (Cya 962, 
Cya 978, Aeg B, Fer A and P 646) under co-culture conditions was observed (NT in NT/NT 
versus NT in WT/NT, Fig. 2B). 
8 
 
The cell-free supernatant of the strains under mono- and co-culture conditions was 
analyzed by HPLC-MS/MS in order to determine whether the major compounds detected in the 
intracellular fraction are released into the media by the cells due to lysis and/or active transport. 
Most of the compounds detected in the intracellular fractions were also detected in the media of 
the three strains in mono- and co-culture experiments (Fig. 3A and B), except the compound Arg 
684 that was not detected in the media in both co-culture experiments (Fig. 3A). Compounds 
detected at higher concentrations in MT cells compared to the WT were not necessarily found at 
higher concentrations in the MT media (WT in WT/WT versus MT in MT/MT; Fig. 3A), except 
for Arg 684 and Cya A. Likewise, only Cya 963A in WT/MT co-culture (Fig. 3A) and Aeg B 
and C in WT/NT co-culture (Fig. 3B) were detected at a significantly higher concentration in the 
media under co-culture than under monoculture. In co-culture conditions, the relative 
concentrations of compounds were not significantly different between the two compartments as 
expected from diffusion of dissolved compounds across the membrane (data not shown).  
Molecular networking as a powerful tool for identification and relative quantification of 
analogues and unknown compounds. Ionizable metabolomes of the three strains under the 
different culture conditions were subjected to mass spectral networking and searched against 
annotated reference spectra in the GNPS spectral library. The resulting network of WT and MT 
intra- and extracellular metabolomes under mono- and co-culture conditions represented 263 
total nodes (Fig. 4A). Analysis of the molecular networking data resulted in dereplication of MC-
LR, Des-MCLR (Fig. 4B), Cya A, B, C, 963A and 895 (Fig. 4C and D), Aer A, B, C and D (Fig. 
4E and F) and Arg 684 as a single node.  
The network further confirmed that MC-LR and Des-MCLR were exclusively produced 
by the WT cells in both the mono- and co-culture experiments and were present in the media of 
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monoculture and co-culture with the WT (Fig. 4B).  
The identification of analogues to known compounds via the molecular networking 
approach indicated a cyanopeptolin cluster (Fig. 4C and D) with the presence of two new 
analogues (m/z 918 and 936). Their precursor masses had distinctive fragmentation patterns 
characteristic of the partial structure of cyanopeptolin-type peptides, Ahp-Leu-MePhe, described 
above (Fig. S3). Interestingly, the m/z 975 node corresponded to the hydrated form of Cya A and 
was exclusively present in the media of these strains. The aerucyclamide cluster (Fig. 4E and F) 
had nodes representing two novel analogues with m/z 521 and m/z 643 closely related to Aer A 
and Aer D, respectively.  
Another powerful feature of this approach was the quantitative color-coding of nodes 
according to their origin by using the pie-chart function. To evaluate the accuracy of the spectral 
count quantitation method, a correlation analysis was performed between the spectral counts and 
the internal standard methods. A highly significant correlation was obtained (Pearson’s R2 = 
0.7320, P < 0.0001 for intracellular and R2 = 0.7042, P < 0.0001 for extracellular quantitation, 
Fig. S6). Hence, the spectral count with pie-chart display was considered a reliable proxy for the 
relative quantification of these metabolites. This approach was used to differentiate major 
producers of a given compound from minor ones according to the culture condition. The 
quantitative information given by this representation suggested that compounds (Cya C, 
cyanopeptolin new analogues m/z 896, 918, 936 and aerucyclamide new analogues m/z 521 and 
643; Fig. 4C, D, E and F) were mainly produced by the MT strain. A detailed analysis of the LC-
MS data revealed that these minor compounds were also produced by the WT strain but not 
detected through the molecular networking because of their low abundance. 
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Analysis of the molecular networking data of the WT and NT intra- and extracellular 
metabolomes under mono- and co-culture conditions contained 280 total nodes (Fig. 5A). It 
resulted in dereplication of MCs, Cya A, Cya 963A, Cya 895, Aer A, Aer B, Aer C and Aer D 
produced by WT and Aeg B, Aeg C, Fer A, Fer B and 5 cyanopeptolins produced by NT with the 
partial structure Ahp-Phe-MePhe (Cya 914, 948, 962, 964 and 978; Fig. S4). Three new 
analogues of aeruginosamide (m/z 650, 660 and 749) were present in the media under WT/NT 
co-culture conditions (Fig. 5B). They were also observed in the media of NT strain under 
monoculture conditions but did not appear in the network due to their low abundance. The 
molecular networking of the unknown peptide (P 680), identified as a di-chlorinated compound 
(Fig. S2), indicated the presence of a new analogue (m/z 611) present in the media under co-
culture conditions (Fig. 5C).  
 
Discussion  
This is the first study to describe the potential of Microcystis strains to produce several bioactive 
compounds in response to intraspecific strain interactions. More precisely, we demonstrated 
changes in the relative concentration of a number of small peptides under mono- and co-culture 
conditions.   
  Our innovative purpose-built chamber allowed two different strains to be physically 
separated while sharing a common culture medium allowing the study of intraspecific 
interactions mediated by diffusible signals that can influence the growth of the strains and the 
production of targeted cyanobacterial secondary metabolites. In previous studies, the use of co-
culture chambers without physical contact has facilitated the investigation of chemical 
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communication between interacting planktonic organisms (Microcystis strains in Schatz et al., 
2005, or diatoms/bacteria in Paul et al., 2013).  
LC-MS and molecular networking approaches revealed the high chemodiversity of 
Microcystis. To profile the chemical output from MC- and non-MC-producing Microcystis 
aeruginosa strains, two complementary approaches were used. The LC-MS approach allowed a 
rapid identification of major secondary metabolites while the MS/MS-based molecular 
networking approach helped to visualize and identify structurally related compounds as well as 
unknown ones. A total of 32 peptides were detected, including 8 highlighted only from 
molecular networking. Among them, 14 could be identified as previously described metabolites: 
2 microcystins, 4 cyanopeptolins, 6 cyanobactins and 2 anabaenopeptins. A total of 14 additional 
peptides could be identified as members of known peptide classes (1 Cl2-aeruginosin, 8 
cyanopeptolins, 2 aerucyclamides and 3 aeruginosamides), while 4 peptides remain to be 
characterized (P 680, P 646, P 612 and P 610). Further chemical studies are needed to firmly 
establish their structures. 
We also gained new insight into the wide diversity of secondary metabolites produced by 
these freshwater cyanobacteria as the spectral networks identified a total of 546 compounds. 
Recent genome mining of the studied strains has revealed their potential to produce more natural 
products than the microcystins, cyanopeptolins, aeruginosins, cyanobactins and anabaenopeptins 
(Frangeul et al., 2008; Humbert et al., 2013; Leikoski et al., 2013). The WT and NT genomes 
contain, respectively, 7 and 9 gene clusters involved in the biosynthesis of secondary metabolites 
(Humbert et al., 2013). Notably, they possess the microviridin and microginin biosynthetic gene 
clusters, but none of these compounds were identified in our study, suggesting that they were not 
produced under the growth conditions selected, or alternatively, not detected because their mass 
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spectrometry signals were too weak. In addition, three orphan PKS gene clusters encoded 
unknown compounds were described in these strains (Humbert et al., 2013) including a PKSI 
iterative gene cluster containing halogenase genes that may encode for enzymes involved in the 
biosynthesis of the unidentified but structurally related non-, mono- and dichlorinated peptides 
produced by the NT strain in this study (P 680, P 646, P 612 and P 610). As this PKS1 iterative 
gene cluster was recently found in other cyanobacterial genomes not related to Microcystis 
(Calteau et al., 2014), additional biochemical studies are needed to compare the metabolite 
profiles of the corresponding strains and identify this family of compounds. The expansion of 
genomic mining techniques to predict structures and identify products of new pathways remains 
a challenge and opportunity for the future.  
Microcystis bioactive peptides may have complementary or interchangeable functions. Despite 
their different metabolic profiles, the three strains grew comparably under monoculture 
conditions, as reported for the WT and MT under several growth conditions (Dittmann et al., 
1997; Hesse et al., 2001; Briand et al., 2012). Similarly, an Anabaena mutant with a disrupted 
anabaenopeptilide synthetase grew similarly to the wild-type under variable growth conditions 
(Repka et al., 2004), suggesting that cyanobacterial bioactive compounds are not essential for the 
growth of the producing cells.  
Changes in the intracellular concentrations of peptides between WT and MT strains in 
monoculture were observed. The production of several peptides by MT strain was stimulated 
with a significant increase in concentration up to 12-fold for Arg 684, 8-fold for Cya 963A and 
from 3 to 4-fold for Aer A, B and C over WT, and several new analogues of the cyanopeptolins 
and aerucyclamides were mainly produced by the MT. The addition of purified MC-LR to the 
MT did not affect the level of the other peptides in MT cells, and the intracellular concentration 
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of these other peptides in MT cells remained much higher than in the WT ones. This suggests 
that the MC-LR was not sensed as a signaling peptide regulating the production of the other 
peptides in the MT. Our results are in accordance with those found for an anabaenopeptilide-
deficient mutant of Anabaena sp. 90 (Repka et al., 2004) in which higher concentrations of the 
remaining oligopeptides (anabaenopeptins and microcystins) were observed. A differential 
allocation of the energy used for secondary metabolism between the WT and the MT may 
explain the observed quantitative changes in intracellular metabolic profiles. The MT may 
allocate more energy in the production of the remaining peptides. Alternatively, compensatory 
intracellular mechanisms might cause the observed effect, as they were also observed within 
classes of peptides in Microcystis aeruginosa PCC 7806 (Tonk et al., 2009), in Planktothrix 
agardhii NIVA-CYA 126/3 strain (Tonk et al., 2005) and in Radiocystis fernandoii (Pereira et 
al., 2012). These studies suggest the possibility of a compensation for the absence or decreased 
production of one compound by increasing the production of others and that these compounds 
may have interchangeable or complementary functions. A further suggestion of a mutual 
function of these cyanobacterial metabolites would be a common distribution of a group of 
secondary metabolites within a species. Recently, the microcystins, aeruginosins and 
cyanopeptolins were reported as the most widely distributed secondary metabolites in 
Microcystis (Humbert et al., 2013), while anabaenopeptins, cyanopeptolins and microcystins are 
metabolites that occurred most frequently in Planktothrix (Kurmayer et al., 2014). Further 
genome sequencing efforts of cyanobacterial species are required to study the distribution of 
genes involved in the biosynthesis of cyanobacterial secondary metabolites.  
Co-culture enhanced the production of Microcystis bioactive peptides. Under co-culture 
conditions, although no significant difference between the WT and MT growth rates was 
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observed, the NT strain displayed a higher growth rate than the WT strain. Previous co-culture 
studies involving direct cell contact, between WT and MT strains (Van de Waal et al., 2011; 
Briand et al., 2012) and between MC- and naturally non-MC-producing Microcystis aeruginosa 
strains (Kardinaal et al., 2007; LeBlanc Renaud et al., 2011; Van de Waal et al., 2011; Lei et al., 
2015) or Planktothrix agardhii strains (Briand et al., 2008), showed differences in the fitness of 
the compared strains under different growth conditions. However, these differences cannot be 
easily compared due to the diversity of abiotic factors tested and the specificity and 
ecophysiology of the different strains studied, highlighting the difficulty to predict clear 
competition outcome. We suggested in a previous related study (Briand et al., 2012) that 
differences in the fitness between monocultures and co-cultures with physical contact were 
attributable to cooperation processes involving diffusive chemicals. However, in the absence of 
physical contact as highlighted in this study, it cannot be ruled out that WT-derived compounds 
may induce chemical signals facilitating the growth of the NT strain. Rather than MC-LR that 
was found not to be the inducible metabolite (Briand et al., 2012; this study), compounds 
exclusively detected in the co-culture media (yellow nodes in molecular networks) should be 
considered and studied in more details. However, a final answer can only be found through 
bioassay-guided structure elucidation of the active compounds. Taken together, these results 
suggest that cooperation processes may take place preferentially when the cells are physically in 
contact, but additional experiments need to be performed to explore this hypothesis.  
This work shows that even without cell contact, physiological responses to co-culturing 
are reflected in the stimulation of the production of the major produced peptides. Likewise, it 
was previously observed that MC production was increased in WT under co-culture conditions 
with MT (Briand et al., 2012). Moreover, the addition of MC-producing cell extract, external 
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MC-LR, micropeptin or microginin induced a specific response on secondary metabolite gene 
expression (Schatz et al., 2007; Makower et al., 2014). Although in this study, the addition of 
MC-LR did not affect the synthesis of the other metabolites, it cannot be ruled out that MCs 
and/or other secondary metabolites may play roles in cell-to-cell communication and that the 
expression of these metabolites may be interrelated, as suggested in previous studies (Schatz et 
al., 2007; Makower et al., 2014). Likewise, the compound Arg 684, that was present in WT and 
MT monoculture media, was not detected in the co-culture media (WT/MT and WT/NT), 
indicating an obvious interaction involving released metabolites. Inhibition of excretion or 
transformation of this compound by the co-cultured strains might cause the observed effect. Co-
culture experiments are a powerful experimental approach that have enhanced the production of 
constitutively present compounds and/or induced silent gene clusters in order to reveal an 
increased chemical diversity of microorganisms (mainly bacteria and fungi) (Bertrand et al., 
2014; Marmann et al., 2014). From an ecological perspective, co-cultures mimic ecological 
situations as microorganisms always co-exist within complex microbial communities, and thus 
are useful to the study of intra- and interspecies interactions (Paul et al., 2013; Schatz et al., 
2005; Briand et al., 2012). 
Role and ecological relevance of cyanobacterial bioactive peptides. The production of a range 
of peptide variants with interchangeable or complementary functions may provide cyanobacteria 
with a competitive advantage in a variable environment through inter- and intraspecific 
interactions. Indeed, it should be an ecological advantage for species to co-exist with chemically 
diverse strains: (1) as defensive compounds against grazers (Wiegand and Pflugmacher, 2005; 
Agrawal and Agrawal, 2011; Penn et al., 2014; Sadler and von Elert, 2014), (2) as allelopathic 
metabolites against other cyanobacteria, algae and plants (Leão et al., 2009; Svercel, 2013), or 
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(3) to provide resistance against rapidly evolving parasites (chytrid fungi, cyanophages). It has 
recently been shown that microcystins, microviridins and anabaenopeptins can reduce the 
virulence of parasitic chytrid fungi to Planktothix due to inhibition of chytrid proteases that are 
involved in their pathogenicity (Rohrlack et al., 2013). Because cyanobacterial metabolites are 
predominantly intracellular, a biological role of cyanopeptides as defense mechanisms against 
fungal parasites and most likely other pathogens which are endocellular parasites is highly 
plausible. From this study, a further indication of the intracellular compartmentalization of these 
bioactive compounds was suggested. The absence of higher concentrations of metabolites in the 
media in relation to higher concentrations measured in the cells suggested that the studied 
cyanopeptides are only modestly released. Numerous studies suggested an intracellular role of 
MC giving competitive advantage to the toxic strains under different abiotic conditions. These 
include putative roles in the tolerance of oxidative stress (Alexova et al., 2011; Zilliges et al., 
2011) or in carbon metabolism (Van de Waal et al., 2011). Hence, we can wonder whether the 
expression and the production of the other peptides are modified under stress conditions. 
Subsequent studies will have to be undertaken to further explore the regulation of the overall 
secondary metabolites in response to biotic and abiotic stress conditions. Most likely, these 
secondary metabolites have several functions, thus allowing cyanobacteria to efficiently colonize 
and dominate highly variable aquatic environments. However, the lack of field studies, showing 
the presence of active substances in the environment and their effect on target organisms, is 
evident and needs to be filled.  
 
Experimental procedures 
Co-culture setup 
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A purpose-built (Plexiglas) growth incubator was constructed in-house (SIO), in which two 
cultures were physically separated by a 0.45 µm cellulose nitrate membrane filter (Whatman, 
Buckinghamshire, UK) that enabled the passage of fluids and dissolved substances, but not cells 
(Fig. 6).  
The exchange of dissolved organic compounds between the two chambers was tested 
knowing that compounds of around 100 Da diffuse within the first few hours (Paul et al., 2013). 
Thus, we monitored after 12, 24, 48 and 72 h the diffusion of the MC-LR standard (995 Da, 
Abraxis-LLC, Warminster, PA, USA, 0.1 mg l-1 final concentration), one of the highest 
molecular weight metabolites produced by the studied strains. The concentration of MC-LR 
nearly reached equilibrium between the two compartments within 48 h (Fig. S7). 
Strains and culture conditions 
Three axenic M. aeruginosa strains with different metabolic profiles (Frangeul et al., 2008; 
Humbert et al., 2013) were used: the MC-producing PCC 7806 (WT), a non-MC-producing 
mutant of PCC 7806 (MT, Dittmann et al., 1997) and a naturally occurring non-MC-producing 
strain PCC 9432 (NT). The cultures were cultivated in BG110 medium supplemented with 1.8 
mM of NaNO3 and 10 mM of NaHCO3 (hereafter BG110 modified medium, Rippka and 
Herdman, 1992) and 5 µg ml-1 of chloramphenicol was added to the MT. The cultures grown 
under a 12:12 h light:dark regime using daylight white fluorescent tubes (Toshiba, 15 W, 
FL15D) with 35 µmol m-2 s-1 illumination at a constant temperature of 23 ˚C. The cultures were 
maintained in exponential growth phase by repeated dilution in fresh culture medium, while the 
axenicity was regularly evaluated as in Briand et al. (2012). The strains are available from the 
Pasteur Culture collection of Cyanobacteria (http://cyanobacteria.web.pasteur.fr/). 
Mono- and co-culture experiments 
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Monocultures of each strain (WT/WT, MT/MT and NT/NT) in duplicate were initiated by 
inoculation of 2.5 × 106 cells ml-1 in each culture chamber. Inoculates of cultures were 
centrifuged (10 min at 4000 × g and 23 ˚C) and washed with sterile Milli-Q water twice before 
being added to the respective chamber containing 425 ml of BG110 modified medium without 
Cm in order to exclude any impact of the antibiotic on cellular metabolism. Co-culturing 
experiments (WT/MT) and (WT/NT) in triplicate were inoculated into both chambers under the 
same culture conditions. The devices were gently shaken manually twice a day. Samples (1 ml) 
were withdrawn every two days to estimate cell growth. In addition, a monoculture of MT 
supplemented with MC-LR (0.1 mg l-1 final concentration) was performed to investigate the 
possible role of the purified toxin on growth and/or secondary metabolite profiles of MT. 
Growth monitoring 
Microcystis growth was estimated by converting optical density (OD) at 750 nm, measured using 
a DU 800 spectrophotometer (Beckman Coulter, Brea, CA, USA), into cell abundance (cells ml-
1) based on the highly significant positive correlation between these two parameters (R2 = 
0.9547, N = 50; P < 0.0001, data not shown). Cell abundance was estimated using a Neubauer 
counting chamber with an Olympus IX51 inverted microscope at 400× magnification (Olympus 
Optical Co, Tokyo, Japan). Growth rates were calculated during the exponential growth phase 
according to the following equation: (ln N2 – ln N1) / (t2 – t1), where N1 and N2 are cell densities 
at time t1 and t2, respectively. 
Sampling, extraction and internal standard addition 
At the end of the experiment (day 12, corresponding to the end of the exponential growth phase), 
the volume of each chamber was harvested separately and centrifuged (for 10 min at 4000 × g 
and 23 ˚C). Freeze-dried biomass was extracted up to three times in 2:1 dichloromethane: 
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methanol (DCM:MeOH, JT Baker, Center Valley, PA, USA) and were evaporated to dryness. 
The supernatants were extracted on SPE-C18 cartridges (GracePureTM, 5000 mg, Columbia, MD, 
USA). Samples were evaporated to dryness under N2 and kept frozen until analysis.  
Dry intra- and extracellular extracts were dissolved with acetonitrile (ACN, EMD 
Chemicals, Gibbstown, NJ, USA) and internal standard (BOC-L-protected Ornithine, 0.25 mg 
ml-1 in ACN, Chem-Impex International, Wood Dale, IL, USA) were added before HPLC-
MS/MS analysis. 
High-performance liquid chromatography electrospray ionization mass spectrometry (HPLC-
ESI-MS/MS) analysis 
Each sample (20 µl) was injected twice into a reverse-phase HPLC system using a Phenomenex 
Kinetex C18 column (5 μm, 100 mm × 4.60 mm) with a gradient of 5%-99% ACN in water with 
0.1 % formic acid over 12 min, held at 99% for 5 min, and then returned to 5% at 22 min for 
another 3 min. The solvents were LC-MS grade (JT Baker, Center Valley, PA, USA). The flow 
rate was 0.7 ml min-1. 
The HPLC eluate was electrospray ionized (capillary temperature at 325 °C, source 
voltage at 5 kV and a sheath gas flow rate of 69 l min-1) and analyzed in the positive mode in the 
mass range of m/z from 300 to 2000 using a Thermo-Finnigan LCQ Advantage ion trap mass 
spectrometer (Thermo-Finnigan, San Jose, CA, USA). MS/MS spectra were obtained in a data-
dependent manner using collision-induced dissociation at 35 eV.  
Identification of metabolites, molecular networking and relative quantification 
We used two complementary approaches to identify cyanobacterial secondary metabolites. In the 
first approach, mass spectra were scanned for molecular ion masses of known peptides and their 
respective adducts (e.g. sodium adducts with Δm = 22 Da compared to the singly protonated 
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molecular mass), and loss of water peaks (Δm = 18 Da). Further, the mass differences between 
and the relative intensity of isotopic peaks were analyzed to gain information on the presence of 
possible halogen atoms (e.g. chlorine, bromine). MS/MS data were then analyzed for indicative 
fragments or series of fragments by comparison to fragment spectra of known peptides according 
to Welker et al. (2006).  
In our second approach, we applied a MS/MS-based Molecular Networking (Wartrous et 
al., 2012). The MS/MS data were subjected to the Molecular Networking workflow of Global 
Natural Products Social Molecular (GNPS at gnps.ucsd.edu, M. Wang et al., in preparation) 
using the Group Mapping feature. The input data were simultaneously searched against 
annotated reference spectra in the GNPS spectral library. Algorithms assumed a precursor mass 
tolerance of 2 Da and a fragment mass tolerance of 0.5 Da. Pairs of consensus spectra were 
aligned if both spectra fell within the top 10 alignments for each of the respective spectra, the 
cosine of their peak match scores was ≥ 0.7 and the minimum matched peaks was 6. The 
maximum size of connected components allowed in the network was 50 and the minimum 
number of spectra to form a cluster was 2. The networks were visualized in the software program 
Cytoscape (Smoot et al., 2011), where consensus spectra are represented as nodes connected by 
edges to aligning nodes. If different strains in different growth conditions were found to produce 
the same compound, then that compound’s node was represented with a multi-colored pie chart 
(Winnikoff et al., 2014). To further simplify the network, the background nodes from solvent 
and internal standard were removed.  
In order to compare relative concentrations of specific metabolites between different 
treatments, the peak area was determined with the software Xcalibur (Thermo) using the Peak 
Detection Genesis Algorithm. The quantification was based on the ratio of the peak area of 
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metabolites and the added internal standard, BOC-L-protected ornithine. Data were then 
normalized to the dry weight for intracellular metabolites and to the volume for extracellular 
metabolites as described in Winnikoff et al. (2014). 
Statistical analysis  
Differences in growth rates and normalized relative concentrations were evaluated using One-
way ANOVA with Tukey’s post test or Two-tailed t-test. The analyses were conducted with the 
software Graphpad Prism 4.00 (San Diego, CA, USA). In all cases, differences were accepted as 
significant when P < 0.05. Values are given as mean ± standard deviation (SD). 
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Table and Figure legends 
Table 1. Growth rates of the wild type PCC 7806 (WT), its MC-deficient mutant (MT, with or 
without addition of MC-LR standard) and the PCC 9432 (NT) strains in mono- and co-culture 
(WT/MT, WT/NT) conditions. Different letters indicate significant difference. Tukey’s test, P < 
0.05 after one-way analysis of variance (ANOVA). 
 
Table 2. Peptides produced by the studied strains. 
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Fig. 1. Chromatograms obtained for WT (A), MT (B) and NT (C) in monoculture. Peaks legend 
(full names are given in Table 2): 1- Arg 684, 2- Aer D, 3- Des-MCLR, 4- MCLR, 5- Cya B, 6- 
Cya C, 7- Cya A, 8- Cya 963A, 9- Cya 895, 10- Aer A, 11- Aer C, 12- Aer B, 13- P 612, 14- P 
646, 15- P 680, 16- Aeg B, 17- Aeg C, 18- Fer A, 19- Fer B, 20- Cya 964, 21- Cya 978, 22- Cya 
914, 23- Cya 948, 24- Cya 962, IS: Internal Standard (retention time = 12.6 min). 
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Fig. 2. Relative concentrations given as a fold change over WT (A) or NT (B) in monoculture of 
selected intracellular compounds for WT, MT and NT strains under mono- (WT/WT, MT/MT, 
NT/NT) and co-culture (WT/MT, WT/NT) conditions and statistical results. MC: Microcystin, 
Arg: Aeruginosin, Cya: Cyanopeptolin, Aer: Aerucyclamide, Aeg: Aeruginosamide, Fer: 
Ferintoic acid. 
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Fig. 3. Relative concentrations given as a fold change over WT (A) or NT (B) in monoculture of 
selected extracellular compounds for WT, MT and NT strains under mono- (WT/WT, MT/MT, 
NT/NT) and co-culture (WT/MT, WT/NT) conditions and statistical results. MC: Microcystin, 
Arg: Aeruginosin, Cya: Cyanopeptolin, Aer: Aerucyclamide, Aeg: Aeruginosamide, Fer: 
Ferintoic acid, nd: not detected. 
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Fig. 4. A) WT and MT intra- and extracellular molecular network under mono- (WT/WT, 
MT/MT) and WT/MT co-culture conditions. Larger circles indicate matches with the GNPS 
library. B) Molecular network of MS/MS spectra of microcystin variants: MC-LR (m/z 995) and 
Des-MCLR (m/z 981). C) and D) Molecular network of MS/MS spectra of cyanopeptolin 
variants with the common structure Ahp-Leu-MePhe. E) and F) Molecular network of MS/MS 
spectra of aerucyclamide variants. 
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Fig. 5. A) WT and NT intra- and extracellular molecular network under mono- (WT/WT, 
NT/NT) and WT/NT co-culture conditions. Larger circles indicate matches with the GNPS 
library. B) Molecular network of MS/MS spectra of aeruginosamide variants. Compounds 
produced by WT are in black rectangles and those produced by NT are in grey ones. C) 
Molecular network of MS/MS spectra of unknown peptides. 
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Fig. 6. Co-culture device to grow strains without physical contact but ensuring the exchange of 
dissolved solutes including secondary metabolites. A) The disassembled device with all parts 
required for the setup, and B) the assembled co-culture device. A 0.45 µm membrane separates 
both chambers that can each be filled with up to 425 ml medium. The two chambers were held 
together by four screws and sealed with an O-ring. Each culturing chamber had a 20 mm opening 
at the top for filling and sampling purposes. The black bar represents 10 cm. 
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Supporting information 
Additional Supporting Information may be found in the online version of this article at the 
publisher’s web-site: 
Fig. S1. Identification of Cl2-aeruginosin 684. The WT and MT strains produced an aeruginosin 
with a mass of m/z 685Da. This compound presented an isotopic pattern corresponding to a 
dichlorinated peptide (detection of pseudo-molecular peaks of M+, M+2 and M+4 Da, top). Its 
fragmentation pattern was characteristic of the aeruginosins with two intense fragments peaks at 
m/z 140 and 122 Da indicative of the Choi-immonium ion and its dehydrated derivative (bottom, 
Welker et al., 2006).  
 
Fig. S2. Identification of three new structural related compounds (P 612, 646 and 680). Partial 
mass spectrum of NT strain showing three molecular ion peaks (m/z 613, 647 and 681) with a 34 
Da increment indicative of non-, mono- and dichlorinated variants of a peptide. This was also 
supported by the detection of pseudo-molecular ion peaks (M+2 Da) with increasing relative 
intensity, corresponding well to theoretical isotopic patterns for chlorinated peptides. 
 
Fig. S3. Identification of cyanopeptolins variants produced by WT and MT strains. MS/MS data 
of each variants: A) Cya A, B) Cya B, C) Cya C, D) Cya 895 and E) Cya 963A. Grey bars 
indicate fragment series used to distinguish cyanopeptolins.  
 
Fig. S4. Identification of cyanopeptolins variants produced by NT strain. MS/MS data of each 
variant: A) Cya 914, B) Cya 948, C) Cya 962, D) Cya 964 and E) Cya 978. Grey bars indicate 
fragment series used to distinguished cyanopeptolins. 
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Fig. S5. Relative concentrations given as a fold change over WT in monoculture of selected 
intracellular compounds for WT, MT and MT with MC-LR under mono- (WT/WT, MT/MT) and 
co-culture (WT/MT) conditions and statistical results. MC: Microcystin, Arg: Aeruginosin, Cya: 
Cyanopeptolin, Aer: Aerucyclamide. 
 
Fig. S6. Correlation between the relative concentrations of major compounds produced in the 
WT/MT experiment determined by the addition of internal standard and by the spectral counts 
obtained for each compound and represented by the pie-chart. A) Intracellular compounds and B) 
extracellular compounds. 
 
Fig. S7. Over time diffusion of MC-LR through a 0.45 µm membrane in co-culture chambers. 
